LON:BVXP - Bioventix Stock Price, News, & Analysis

GBX 3,688
-32.00 (-0.86 %)
(As of 06/18/2019 08:38 AM ET)
Today's Range
Now: GBX 3,688
50-Day Range
MA: GBX 3,826.56
52-Week Range
Now: GBX 3,688
Volume1,606 shs
Average Volume5,505 shs
Market Capitalization£189.66 million
P/E Ratio34.53
Dividend Yield1.78%
Bioventix PLC manufactures and supplies sheep monoclonal antibodies (SMAs) for use in blood-testing machines in hospitals and other labs worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. Read More…

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual Sales£8.82 million
Cash FlowGBX 105.29 per share
Book ValueGBX 178.30 per share



Market Cap£189.66 million
Next Earnings DateN/A
OptionableNot Optionable

Receive BVXP News and Ratings via Email

Sign-up to receive the latest news and ratings for BVXP and its competitors with MarketBeat's FREE daily newsletter.

Bioventix (LON:BVXP) Frequently Asked Questions

What is Bioventix's stock symbol?

Bioventix trades on the London Stock Exchange (LON) under the ticker symbol "BVXP."

How often does Bioventix pay dividends? What is the dividend yield for Bioventix?

Bioventix declared a dividend on Friday, March 29th. Shareholders of record on Thursday, April 11th will be paid a dividend of GBX 30 per share on Friday, April 26th. This represents a yield of 0.79%. The ex-dividend date of this dividend is Thursday, April 11th. The official announcement can be viewed at this link. View Bioventix's Dividend History.

What price target have analysts set for BVXP?

0 Wall Street analysts have issued 12 month target prices for Bioventix's stock. Their predictions range from GBX 3,700 to GBX 3,700. On average, they expect Bioventix's stock price to reach GBX 3,700 in the next year. This suggests a possible upside of 0.3% from the stock's current price. View Analyst Price Targets for Bioventix.

Has Bioventix been receiving favorable news coverage?

News stories about BVXP stock have trended negative on Tuesday, according to InfoTrie Sentiment. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Bioventix earned a news impact score of -2.3 on InfoTrie's scale. They also gave news stories about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for Bioventix.

Who are some of Bioventix's key competitors?

What other stocks do shareholders of Bioventix own?

Who are Bioventix's key executives?

Bioventix's management team includes the folowing people:
  • Mr. Peter J. Harrison MA, CEO & Director (Age 61)
  • Ms. Treena Turner, Fin. Director & Director

How do I buy shares of Bioventix?

Shares of BVXP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Bioventix's stock price today?

One share of BVXP stock can currently be purchased for approximately GBX 3,688.

How big of a company is Bioventix?

Bioventix has a market capitalization of £189.66 million and generates £8.82 million in revenue each year. Bioventix employs 12 workers across the globe.View Additional Information About Bioventix.

What is Bioventix's official website?

The official website for Bioventix is http://www.bioventix.com/.

How can I contact Bioventix?

Bioventix's mailing address is 7 Romans Business Park, East Street, FARNHAM, GU9 7SX, United Kingdom. The biotechnology company can be reached via phone at +44-1252-728001.

MarketBeat Community Rating for Bioventix (LON BVXP)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  75 (Vote Outperform)
Underperform Votes:  146 (Vote Underperform)
Total Votes:  221
MarketBeat's community ratings are surveys of what our community members think about Bioventix and other stocks. Vote "Outperform" if you believe BVXP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BVXP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel